Prognia
Drug Database
🇺🇸US · FDA ApprovedDiscontinuedNDA011522-011

ADDERALL 7.5(AMPHETAMINE ASPARTATE)

Centrally acting sympathomimetics

Manufacturer: TEVA WOMENS

FDA Approval: 19/01/1960

Route: ORAL · TABLET

Active Ingredients

AMPHETAMINE ASPARTATE 1.875MG; AMPHETAMINE SULFATE 1.875MG; DEXTROAMPHETAMINE SACCHARATE 1.875MG; DEXTROAMPHETAMINE SULFATE 1.875MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ADDERALL 7.5 — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.